oral semaglutide cardiovascular outcomes soul trial results 2024 2025 🔴Cardiovascular with by severity of chronic kidney disease in type 2 diabetes: the FLOW trial⤵️ 🔹Semaglutide significantly reduced the risk of CV death/MI/stroke regardless of baseline CKD severity in participants Oral Semaglutide Approved to Reduce

Tirzepatide continues to be the most prescribed anti-diabetic (ADM) and anti-obesity (AOM) medication (sold as Mounjaro and Zepbound, respectively) and showed the largest increase in total prescribing from September to December 2025

Semaglutide & Tirzepatide: The Future of Weight Loss Discover a new approach to weight loss with Semaglutide and Tirzepatide

Burn Injury Burn injuries cause immense pain and long-term challenges

The management of oral amelanotic melanoma generally includes a combination of surgical intervention and radiotherapy or chemotherapy

Equally important are non-physician healthcare professionals such as dietitians, diabetes care and education specialists, podiatrists, and exercise physiologists, who provide essential lifestyle and self-management support [7]

In addition, the combination of metformin and TZDs has a synergistic effect in the treatment of women with PCOS, conferring greater improvement in IR and menstrual frequency in PCOS than metformin alone [215]